wsj.com

Source: wsj.com

A small autism therapy company called Cardiff received huge Medicaid payments for treating only a handful of patients with intensive behavioral therapy. New York state officials reviewed the claims and decided the treatments weren't medically necessary, so they banned the firm from the program. This story exposes weaknesses in how governments pay for autism services, which cost billions and are hard to regulate.